TRIARM THERAPEUTICS
TriArm Therapeutics is a cell therapy company formed by Panacea Venture with R&D operations in Germany, United States and Greater China region. The company focuses on the research and clinical transformation of CD19 CAR-T product using non-viral gene transfer technology, which greatly reduces the cost and time of cell therapy product preparation, enabling better tumor therapy outcome.
TRIARM THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
2018-01-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.triarmbio.com
Total Employee:
11+
Status:
Active
Total Funding:
20 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving ASP.NET DigiCert SSL Encryption Everywhere Alibaba HiChina DNS
Similar Organizations
Carrick Therapeutics
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Gracell Biotechnologies
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
JW Therapeutics
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.
Neukio Biotherapeutics
Neukio Biotherapeutics is a developer of allogenic immune cell therapies for treatment of cancer.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
Founder
Investors List
Panacea Venture
Panacea Venture investment in Series A - TriArm Therapeutics
HT Capital
HT Capital investment in Series A - TriArm Therapeutics
EFung Capital
EFung Capital investment in Series A - TriArm Therapeutics
Lombard Odier
Lombard Odier investment in Series A - TriArm Therapeutics
Virtus Inspire Ventures
Virtus Inspire Ventures investment in Series A - TriArm Therapeutics
Official Site Inspections
http://www.triarmbio.com
- Host name: catl.com
- IP address: 203.107.45.167
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
